%0 Journal Article
%T SweetĄŻs Syndrome (SS) in the Course of Acute Myeloid Leukaemia (AML)
%A Claudio Guarneri
%A Georgi Konstantinov Maximov
%A Georgi Tchernev
%A Ilia Lozev
%A Ivan Pidakev
%A Jacopo Lotti
%A Serena Gianfaldoni
%A Torello Lotti
%A Uwe Wollina
%J Archive of "Open Access Macedonian Journal of Medical Sciences".
%D 2018
%R 10.3889/oamjms.2018.006
%X Firstly described by Robert Douglas Sweet in 1964, febrile neutrophilic dermatosis is a disabling, not only cutaneous disorder, clinically characterised by fever and painful erythematous nodules, with a typical background of neutrophilia. SweetĄŻs syndrome (SS) is a chronic inflammatory reactive disorder of unknown cause and incompletely established pathogenesis, although an interplay between genetic and environmental factors, including infections, is likely to occur. A significant part of cases has been demonstrated to be linked with malignancies, especially in the hematologic setting. Because of the underlying disease and related therapeutic measures, SS may present atypical clinical course, whereas the response to treatment is strictly dependent on the concurrent hematologic disease. Herein we describe a case of a lady who had a refractory form of SS, resulted in a paraneoplastic cutaneous disease, and AML. Surprisingly, clinical remission of SS followed cytotoxic chemotherapy while hematologic disorder obtained a further complete response
%K Sweet syndrome
%K Acute leukaemia
%K Complete response
%K Epirubicin
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816273/